These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 348294)
1. Comparison of methyl-CCNU and CCNU in patients with advanced forms of Hodgkin's disease, lymphosarcoma nad reticulum cell sarcoma. Maurice P; Glidewell O; Jacquillat C; Silver RT; Carey R; Pas AT; Cornell CJ; Burningham RA; Nissen NI; Holland JF Cancer; 1978 May; 41(5):1658-63. PubMed ID: 348294 [TBL] [Abstract][Full Text] [Related]
2. The superiority of CCNU in the treatment of advanced Hodgkin's disease: Cancer and Leukemia Group B Study. Hansen HH; Selawry OS; Pajak TF; Spurr CL; Falkson G; Brunner K; Cuttner J; Nissen NI; Holland JF Cancer; 1981 Jan; 47(1):14-8. PubMed ID: 7006789 [TBL] [Abstract][Full Text] [Related]
3. Results with CCNU in resistant Hodgkin's and non-Hodgkin's lymphoma. Stolinsky DC; Solomon J; Weiner JM; Bateman JR Oncology; 1976; 33(5-6):271-3. PubMed ID: 800240 [TBL] [Abstract][Full Text] [Related]
4. Southeastern Cancer Study Group trials with nitrosoureas in Hodgkin's disease. Durant JR; Bartolucci A; Gams RA; Dorfman RF; Velez-Garcia E Cancer Treat Rep; 1976 Jun; 60(6):781-7. PubMed ID: 782700 [TBL] [Abstract][Full Text] [Related]
5. Methyl-CCNU versus methyl-CCNU and 5-fluorouracil in carcinoma of the large bowel. Posey LE; Morgan LR Cancer Treat Rep; 1977 Nov; 61(8):1453-8. PubMed ID: 922750 [TBL] [Abstract][Full Text] [Related]
6. Results with methyl-CCNU and DTIC in metastatic melanoma. Costanza ME; Nathanson L; Schoenfeld D; Wolter J; Colsky J; Regelson W; Cunningham T; Sedransk N Cancer; 1977 Sep; 40(3):1010-5. PubMed ID: 332319 [TBL] [Abstract][Full Text] [Related]
7. Chemotherapy for mustard-resistant ovarian adenocarcinoma: a randomized trial for CCNU and methyl-CCNU. Omura G; DiSaia P; Blessing J; Boronow R; Hreshchyshyn M; Park R Cancer Treat Rep; 1977 Nov; 61(8):1533-5. PubMed ID: 922756 [TBL] [Abstract][Full Text] [Related]
8. Bleomycin (NSC-125066) and CCNU (NSC-79037) in the combination chemotherapy of mopp-resistant hodgkin's disease. Kurnick JE; White M; Ware DE; Robinson WA Cancer Chemother Rep; 1975; 59(6):1147-50. PubMed ID: 56989 [TBL] [Abstract][Full Text] [Related]
9. A phase II study of intravenously- administered methyl CCNU in the treatment of advanced sarcomas. Chang P; Levine MA; Wiernik PH; Walker MD Cancer; 1976 Feb; 37(2):615-9. PubMed ID: 766946 [TBL] [Abstract][Full Text] [Related]
10. Methyl CCNU and adriamycin for patients with metastatic sarcomas: a Southwest Oncology Group study. Rivkin SE; Gottlieb JA; Thigpen T; El Mawla NG; Saiki J; Dixon DO Cancer; 1980 Aug; 46(3):446-51. PubMed ID: 7397620 [TBL] [Abstract][Full Text] [Related]
11. Trial of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in advanced bronchogenic carcinoma 1,2,3. Stolinsky DC; Bull FE; Pajak TF; Bateman JR Oncology; 1975; 31(5-6):288-92. PubMed ID: 174040 [TBL] [Abstract][Full Text] [Related]
12. Cyclophosphamide, vinblastine, procarbazine and prednisone with CCNU and vinblastine maintenance for advanced Hodgkin's disease. Diggs CH; Wiernik PH; Levi JA; Kvols LK Cancer; 1977 May; 39(5):1949-54. PubMed ID: 870162 [TBL] [Abstract][Full Text] [Related]
13. Chemotherapy of gynecologic cancer with nitrosoureas: a randomized trial of CCNU and methyl-CCNU in cancers of the cervix, corpus, vagina, and vulva. Omura GA; Shingleton HM; Creasman WT; Blessing JA; Boronow RC Cancer Treat Rep; 1978 May; 62(5):833-5. PubMed ID: 350400 [No Abstract] [Full Text] [Related]
14. Combination with 5-fluorouracil, methyl-CCNU and beta-2-deoxythioguanosine in advanced colo-rectal adenocarcinoma. Cedermark BJ; Kaufman JH; Douglass HO; Mittelman A Clin Oncol; 1977 Mar; 3(1):27-31. PubMed ID: 862274 [No Abstract] [Full Text] [Related]
15. Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer. Douglass HO; Lavin PT; Moertel CG Cancer Treat Rep; 1976 Jun; 60(6):769-80. PubMed ID: 782699 [TBL] [Abstract][Full Text] [Related]
17. Methyl-CCNU (NSC-95441) in advanced colorectal carcinoma after failure of 5-fluorouracil (NSC-19893) therapy. Cedermark BJ; Didolkar MS; Elias EG Cancer Treat Rep; 1976 Mar; 60(3):235-8. PubMed ID: 769977 [TBL] [Abstract][Full Text] [Related]
18. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone. Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771 [TBL] [Abstract][Full Text] [Related]
19. [Combination chemotherapy of transplanted rat leukemia L 5222 with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and cyclophosphamide (CPA) as well as with methyl-CCNU and CPA (author's transl)]. Zeller WJ; Berger M Arzneimittelforschung; 1981; 31(2):303-5. PubMed ID: 7194646 [TBL] [Abstract][Full Text] [Related]
20. Treatment of advanced malignancy with CCNU (NSC 79037): a phase II cooperative study with long-term follow up. Cruz AB; Metter G; Armstrong DM; Aust JB; Fletcher WS; Wilson WL; Richardson JD Cancer; 1976 Sep; 38(3):1069-76. PubMed ID: 953955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]